Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LSS | P48449 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869621 | 0.90 | TSHR (0.50) | TSHRALDH1A1KDM4ESMN1; SMN2HTT | |
| SCHEMBL30869654 | 0.90 | ALDH1A1 (0.43) | TSHRALDH1A1KDM4ESMN1; SMN2HTT | |
| SCHEMBL30869412 | 0.89 | ALDH1A1 (0.42) | TSHRALDH1A1KDM4ESMN1; SMN2HTT | |
| SCHEMBL30869512 | 0.87 | TSHR (0.42) | TSHRALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL30869550 | 0.82 | TSHR (0.33) | TSHR | |
| SCHEMBL30869467 | 0.82 | — | — | |
| SCHEMBL30869652 | 0.81 | EGFR (0.41) | TSHRALDH1A1KDM4ESMN1; SMN2LSS | |
| SCHEMBL30869680 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL30869590 | 0.80 | PIM1 (0.45) | TSHRALDH1A1HTTMAPT | |
| SCHEMBL30869403 | 0.79 | EGFR (0.43) | TSHRKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | DNM1, DNM1L, DNM2 | TSHR 2846/4885ALDH1A1 4860/4885KDM4E 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.